The global market for DH5α Competent Cells was valued at US$ 196 million in the year 2023 and is projected to reach a revised size of US$ 339 million by 2030, growing at a CAGR of 6.1% during the forecast period.
DH5α Competent Cells are a specific strain of Escherichia coli (E. coli) that has been made competent for DNA uptake, making them ideal for molecular cloning and other genetic manipulation techniques. These cells are commonly used in laboratories due to their reliability, ease of use, and effectiveness in propagating plasmid DNA.
North American market for DH5α Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DH5α Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of DH5α Competent Cells include Merck, Thermo Fisher Scientific, New England Biolabs (NEB), Promega Corporation, Takara Bio, GenScript, LGC Biosearch Technologies, Addgene, Zymo Research, Bio-Rad, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DH5α Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DH5α Competent Cells.
The DH5α Competent Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global DH5α Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DH5α Competent Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Thermo Fisher Scientific
New England Biolabs (NEB)
Promega Corporation
Takara Bio
GenScript
LGC Biosearch Technologies
Addgene
Zymo Research
Bio-Rad
NCM Biotech
Beyotime
Yeasen
TIANGEN
Maokangbio
ZOMANBIO
Segment by Type
Chemically Competent DH5α Cells
Electrocompetent DH5α Cells
Segment by Application
Cloning
Proteomics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DH5α Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DH5α Competent Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 DH5α Competent Cells Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 DH5α Competent Cells by Type
1.2.1 Global DH5α Competent Cells Âé¶¹Ô´´ Value Comparison by Type (2024-2030)
1.2.2 Chemically Competent DH5α Cells
1.2.3 Electrocompetent DH5α Cells
1.3 DH5α Competent Cells by Application
1.3.1 Global DH5α Competent Cells Âé¶¹Ô´´ Value by Application (2024-2030)
1.3.2 Cloning
1.3.3 Proteomics
1.4 Global DH5α Competent Cells Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global DH5α Competent Cells Revenue 2019-2030
1.4.2 Global DH5α Competent Cells Sales 2019-2030
1.4.3 Global DH5α Competent Cells Âé¶¹Ô´´ Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DH5α Competent Cells Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global DH5α Competent Cells Sales Âé¶¹Ô´´ Share by Manufacturers (2019-2024)
2.2 Global DH5α Competent Cells Revenue Âé¶¹Ô´´ Share by Manufacturers (2019-2024)
2.3 Global DH5α Competent Cells Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of DH5α Competent Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DH5α Competent Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DH5α Competent Cells, Product Type & Application
2.7 Global Key Manufacturers of DH5α Competent Cells, Date of Enter into This Industry
2.8 Global DH5α Competent Cells Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global DH5α Competent Cells Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest DH5α Competent Cells Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global DH5α Competent Cells Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DH5α Competent Cells Âé¶¹Ô´´ Scenario by Region
3.1 Global DH5α Competent Cells Âé¶¹Ô´´ Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DH5α Competent Cells Sales by Region: 2019-2030
3.2.1 Global DH5α Competent Cells Sales by Region: 2019-2024
3.2.2 Global DH5α Competent Cells Sales by Region: 2025-2030
3.3 Global DH5α Competent Cells Revenue by Region: 2019-2030
3.3.1 Global DH5α Competent Cells Revenue by Region: 2019-2024
3.3.2 Global DH5α Competent Cells Revenue by Region: 2025-2030
3.4 North America DH5α Competent Cells Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America DH5α Competent Cells Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DH5α Competent Cells Sales by Country (2019-2030)
3.4.3 North America DH5α Competent Cells Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe DH5α Competent Cells Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe DH5α Competent Cells Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DH5α Competent Cells Sales by Country (2019-2030)
3.5.3 Europe DH5α Competent Cells Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DH5α Competent Cells Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific DH5α Competent Cells Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DH5α Competent Cells Sales by Region (2019-2030)
3.6.3 Asia Pacific DH5α Competent Cells Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America DH5α Competent Cells Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America DH5α Competent Cells Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DH5α Competent Cells Sales by Country (2019-2030)
3.7.3 Latin America DH5α Competent Cells Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa DH5α Competent Cells Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa DH5α Competent Cells Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DH5α Competent Cells Sales by Country (2019-2030)
3.8.3 Middle East and Africa DH5α Competent Cells Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DH5α Competent Cells Sales by Type (2019-2030)
4.1.1 Global DH5α Competent Cells Sales by Type (2019-2024)
4.1.2 Global DH5α Competent Cells Sales by Type (2025-2030)
4.1.3 Global DH5α Competent Cells Sales Âé¶¹Ô´´ Share by Type (2019-2030)
4.2 Global DH5α Competent Cells Revenue by Type (2019-2030)
4.2.1 Global DH5α Competent Cells Revenue by Type (2019-2024)
4.2.2 Global DH5α Competent Cells Revenue by Type (2025-2030)
4.2.3 Global DH5α Competent Cells Revenue Âé¶¹Ô´´ Share by Type (2019-2030)
4.3 Global DH5α Competent Cells Price by Type (2019-2030)
5 Segment by Application
5.1 Global DH5α Competent Cells Sales by Application (2019-2030)
5.1.1 Global DH5α Competent Cells Sales by Application (2019-2024)
5.1.2 Global DH5α Competent Cells Sales by Application (2025-2030)
5.1.3 Global DH5α Competent Cells Sales Âé¶¹Ô´´ Share by Application (2019-2030)
5.2 Global DH5α Competent Cells Revenue by Application (2019-2030)
5.2.1 Global DH5α Competent Cells Revenue by Application (2019-2024)
5.2.2 Global DH5α Competent Cells Revenue by Application (2025-2030)
5.2.3 Global DH5α Competent Cells Revenue Âé¶¹Ô´´ Share by Application (2019-2030)
5.3 Global DH5α Competent Cells Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck DH5α Competent Cells Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific DH5α Competent Cells Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 New England Biolabs (NEB)
6.3.1 New England Biolabs (NEB) Company Information
6.3.2 New England Biolabs (NEB) Description and Business Overview
6.3.3 New England Biolabs (NEB) DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.3.4 New England Biolabs (NEB) DH5α Competent Cells Product Portfolio
6.3.5 New England Biolabs (NEB) Recent Developments/Updates
6.4 Promega Corporation
6.4.1 Promega Corporation Company Information
6.4.2 Promega Corporation Description and Business Overview
6.4.3 Promega Corporation DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Promega Corporation DH5α Competent Cells Product Portfolio
6.4.5 Promega Corporation Recent Developments/Updates
6.5 Takara Bio
6.5.1 Takara Bio Company Information
6.5.2 Takara Bio Description and Business Overview
6.5.3 Takara Bio DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takara Bio DH5α Competent Cells Product Portfolio
6.5.5 Takara Bio Recent Developments/Updates
6.6 GenScript
6.6.1 GenScript Company Information
6.6.2 GenScript Description and Business Overview
6.6.3 GenScript DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GenScript DH5α Competent Cells Product Portfolio
6.6.5 GenScript Recent Developments/Updates
6.7 LGC Biosearch Technologies
6.7.1 LGC Biosearch Technologies Company Information
6.7.2 LGC Biosearch Technologies Description and Business Overview
6.7.3 LGC Biosearch Technologies DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.7.4 LGC Biosearch Technologies DH5α Competent Cells Product Portfolio
6.7.5 LGC Biosearch Technologies Recent Developments/Updates
6.8 Addgene
6.8.1 Addgene Company Information
6.8.2 Addgene Description and Business Overview
6.8.3 Addgene DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Addgene DH5α Competent Cells Product Portfolio
6.8.5 Addgene Recent Developments/Updates
6.9 Zymo Research
6.9.1 Zymo Research Company Information
6.9.2 Zymo Research Description and Business Overview
6.9.3 Zymo Research DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zymo Research DH5α Competent Cells Product Portfolio
6.9.5 Zymo Research Recent Developments/Updates
6.10 Bio-Rad
6.10.1 Bio-Rad Company Information
6.10.2 Bio-Rad Description and Business Overview
6.10.3 Bio-Rad DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bio-Rad DH5α Competent Cells Product Portfolio
6.10.5 Bio-Rad Recent Developments/Updates
6.11 NCM Biotech
6.11.1 NCM Biotech Company Information
6.11.2 NCM Biotech Description and Business Overview
6.11.3 NCM Biotech DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.11.4 NCM Biotech DH5α Competent Cells Product Portfolio
6.11.5 NCM Biotech Recent Developments/Updates
6.12 Beyotime
6.12.1 Beyotime Company Information
6.12.2 Beyotime Description and Business Overview
6.12.3 Beyotime DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beyotime DH5α Competent Cells Product Portfolio
6.12.5 Beyotime Recent Developments/Updates
6.13 Yeasen
6.13.1 Yeasen Company Information
6.13.2 Yeasen Description and Business Overview
6.13.3 Yeasen DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yeasen DH5α Competent Cells Product Portfolio
6.13.5 Yeasen Recent Developments/Updates
6.14 TIANGEN
6.14.1 TIANGEN Company Information
6.14.2 TIANGEN Description and Business Overview
6.14.3 TIANGEN DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.14.4 TIANGEN DH5α Competent Cells Product Portfolio
6.14.5 TIANGEN Recent Developments/Updates
6.15 Maokangbio
6.15.1 Maokangbio Company Information
6.15.2 Maokangbio Description and Business Overview
6.15.3 Maokangbio DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Maokangbio DH5α Competent Cells Product Portfolio
6.15.5 Maokangbio Recent Developments/Updates
6.16 ZOMANBIO
6.16.1 ZOMANBIO Company Information
6.16.2 ZOMANBIO Description and Business Overview
6.16.3 ZOMANBIO DH5α Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.16.4 ZOMANBIO DH5α Competent Cells Product Portfolio
6.16.5 ZOMANBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DH5α Competent Cells Industry Chain Analysis
7.2 DH5α Competent Cells Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DH5α Competent Cells Production Mode & Process
7.4 DH5α Competent Cells Sales and Âé¶¹Ô´´ing
7.4.1 DH5α Competent Cells Sales Channels
7.4.2 DH5α Competent Cells Distributors
7.5 DH5α Competent Cells Customers
8 DH5α Competent Cells Âé¶¹Ô´´ Dynamics
8.1 DH5α Competent Cells Industry Trends
8.2 DH5α Competent Cells Âé¶¹Ô´´ Drivers
8.3 DH5α Competent Cells Âé¶¹Ô´´ Challenges
8.4 DH5α Competent Cells Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
Thermo Fisher Scientific
New England Biolabs (NEB)
Promega Corporation
Takara Bio
GenScript
LGC Biosearch Technologies
Addgene
Zymo Research
Bio-Rad
NCM Biotech
Beyotime
Yeasen
TIANGEN
Maokangbio
ZOMANBIO
Ìý
Ìý
*If Applicable.